DAVIES PHARMACEUTICALS

DEAD

Serial Number

97628980

Owner

Davies Pharmaceuticals, LLC

Attorney

Simeon N Wright

First Use Date

Nov 1, 2024

Filing Date

Oct 12, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

DAVIES PHARMACEUTICALS Trademark

Serial Number: 97628980

DAVIES PHARMACEUTICALS is a trademark filed by Davies Pharmaceuticals, LLC on October 12, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Davies Pharmaceuticals, LLC (6 trademarks)

3561 Sunrise Dr.
Crown Point, IN 46307

Entity Type: 16

Legal Representation

Attorney of Record

Simeon N Wright

40 trademarks filed View all →

Correspondence Address

Simeon N Wright Edison Law Group

1201 Connecticut Ave,

Washington, DC 20036

United States

Trademark Details

Filing Date

October 12, 2022

Registration Date

Not Registered

First Use Anywhere

November 1, 2024

First Use in Commerce

November 1, 2024

Goods & Services

Pharmaceutical preparations for the treatment of psychotic and neurological diseases

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Oct 23, 2025 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Oct 23, 2025 ABN2

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 9, 2025 GNRN

NON-FINAL ACTION E-MAILED

Jul 9, 2025 GNRT

NON-FINAL ACTION WRITTEN

Jul 9, 2025 CNRT

USE AMENDMENT ACCEPTED

Jul 9, 2025 IUAA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 30, 2025 TROA

AMENDMENT TO USE PROCESSING COMPLETE

Jun 18, 2025 AUPC

USE AMENDMENT FILED

Jun 18, 2025 IUAF

TEAS AMENDMENT OF USE RECEIVED

Jun 18, 2025 EAAU

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 13, 2025 TCCA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 13, 2025 REAP

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 13, 2025 ARAA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 12, 2025 GNRN

NON-FINAL ACTION E-MAILED

May 12, 2025 GNRT

NON-FINAL ACTION WRITTEN

May 12, 2025 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 12, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 12, 2024 CRFA

ASSIGNED TO LIE

Aug 12, 2024 ALIE

TEAS PETITION TO REVIVE RECEIVED

Feb 26, 2024 PROA

NOTICE OF REVIVAL - E-MAILED

Feb 26, 2024 NREV

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 26, 2024 TROA

PETITION TO REVIVE-GRANTED

Feb 26, 2024 PETG

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Feb 22, 2024 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Feb 22, 2024 ABN2

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Nov 9, 2023 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Nov 9, 2023 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 9, 2023 GNRN

NON-FINAL ACTION E-MAILED

Aug 9, 2023 GNRT

NON-FINAL ACTION WRITTEN

Aug 9, 2023 CNRT

ASSIGNED TO EXAMINER

Jul 27, 2023 DOCK

WITHDRAWAL OF ATTORNEY GRANTED

May 24, 2023 WOAG

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

May 24, 2023 WOAR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 17, 2022 NWOS

NEW APPLICATION ENTERED

Oct 15, 2022 NWAP

Related Trademarks

More from this Owner

DAVIES PHARMACEUTICALS

PROVIDING MEDICATION THAT BENEFITS ALL

Serial #98852060

Serial #97628992

More in Same Class

OMNI CLEANSE

CARE A2+

OMNI ELIXIR

VERIPURE

GAME ON

C.U.P. CAPACITY UNDER PRESSURE